Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events-Reference-Cited by-同舟云学术

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events

Published:2009-10-07 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Cates Christopher J,Lasserson Toby J

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007695.pub2/epdf/full

Reference80 articles.

1. Condemi JJ Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial Clinical Therapeutics 2001 1529 41

2. Everden P Campbell M Harnden C McGoldrick H Bodalia B Manion V Eformoterol Turbohaler compared with salmeterol by dry powder inhaler in asthmatic children not controlled on inhaled corticosteroids Pediatric Allergy & Immunology 2004 40 7

3. Everden P Lloyd A Hutchinson J Plumb J Cost-effectiveness of eformoterol Turbohaler versus salmeterol Accuhaler in children with symptomatic asthma Respiratory Medicine 2002 250 8

4. Everden P Reynia S Lloyd AC Hutchinson JL Plumb JM Economic evaluation of eformoterol compared with salmeterol in children aged 6-17 with symptomatic asthma in the UK: cost-effectiveness results of the FACT study European Respiratory Journal 2001 122s

5. Gabbay MB Kane H di Benedetto G A comparison of formoterol and salmeterol dry powders in the treatment of nocturnal asthma [abstract] European Respiratory Journal. Supplement. 1998 325S

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis;Journal of Drug Assessment;2019-01-01

2. Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD;Drugs;2014-09

3. Long-Acting β2-Agonist Step-off in Patients With Controlled Asthma;Archives of Internal Medicine;2012-10-08

4. Regular treatment with formoterol for chronic asthma: serious adverse events;Cochrane Database of Systematic Reviews;2012-04-18

5. Exacerbations dans l’asthme : prévention pharmacologique;Revue des Maladies Respiratoires;2012-02